TrialDiabetes, obesity & metabolism2020
Assessing patient PREFERence between the dulaglutide pen and the semaglutide pen: A crossover study (PREFER).
Louis S Matza et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
23 papers cite it
this paperpooled ittrialcites it